Notice Regarding Kyowa Kirin Regaining Control of Rocatinlimab Development and Commercialization Program1/30TDnetPDF(137KB)
Announcement regarding the Transition to Company with Audit and Supervisory Committee10/30TDnetPDF(101KB)